Paraquat Certified Pesticide Applicator Files Lawsuit After Parkinson’s Disease Diagnosis

|

A certified pesticide applicator, who underwent training on the safe handling of toxic chemicals, indicates he still developed Parkinson’s disease from exposure to paraquat, alleging the manufacturer failed to warn about the neurological risks which may result from normal handling of the controversial weed and grass killer in a recently filed lawsuit.

Paraquat has been widely used by agricultural workers for decades, even though it has been banned in several countries due to the serious poisoning risks, which can result in fatal injuries if even small amounts are ingested.

The herbicide is heavily restricted in the United States, requiring users to go through special a training and certification process before they are allowed to purchase, mix or spray paraquat. However, the training is largely focused on the risk of Paraquat poisoning, and a growing number of lawsuits now allege manufacturers provided insufficient warnings about the link between paraquat and Parkinson’s disease.

In a complaint (PDF) filed last week in the U.S. District Court for the District of California, Russell Denes indicates that he mixed and applied paraquat over at least three decades, first working for a certified herbicide applicator, then obtaining the license himself.

Certified applicators are taught how to safely and properly mix herbicides and pesticides, how to store it, spray it, and what amounts and formulations to use, as well as the proper safety precautions. However, the lawsuit indicates the makers of paraquat deceived consumers and regulators, meaning that the certified applicator training did not include warnings or precautions that paraquat exposure could cause Parkinson’s disease, which is a serious and progressive neurological disease that causes shaking, stiffness and difficulty walking, balancing and coordinating body movements.

“Although Plaintiff Russell Denes knew that the Paraquat to which he was exposed was acutely toxic, he had no reason to suspect that chronic, low-dose exposure to Paraquat could cause neurological diseases such as Parkinson’s disease,” the lawsuit states. “Plaintiff Russell Denes was never told, either by a medical professional, by media, or by the Defendants, that chronic- low-dose exposure to Paraquat could cause him to suffer Parkinson’s disease.”

Over the past decade, a series of independent studies have established that farmers and agricultural workers exposed to the herbicide are several times more likely to develop the disease, and individuals with certain genetic variations may be 11 times more likely to be diagnosed with Parkinson’s. However, the lawsuit alleges that Syngenta, Chevron and other manufacturers knew or should have known about the risk of Parkinson’s disease after parquat exposure, but failed to warn consumers and regulators.

The case now joins a growing number of paraquat lawsuits now being pursued throughout the U.S. court system, each raising similar allegations that individuals may have avoided a Parkinson’s disease diagnosis if information and warnings had been provided.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.